Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial

被引:1
|
作者
Lucchese, Alessandra [1 ,2 ]
Matarese, Giovanni [3 ]
Manuelli, Maurizio [1 ,2 ]
Ciuffreda, Claudio [1 ,2 ]
Bassani, Luca [1 ,2 ]
Isola, Gaetano [3 ,4 ]
CordaSco, Giancarlo [3 ]
Gherlone, Enrico [1 ,2 ]
机构
[1] IRCCS, San Raffaele Hosp, Dentofacial Orthoped Orthodont & Pediat Dent Oral, Milan, Italy
[2] Univ Vita Salute San Raffaele, Dept Orthodont, Unit Dent, Milan, Italy
[3] Univ Messina, Policlin G Martino, Dept Specialist Med Surg Expt Sci & Odontostomato, Messina, Italy
[4] Univ Federico II Naples, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy
来源
MINERVA STOMATOLOGICA | 2016年 / 65卷 / 01期
关键词
Stomatitis; Fibroblast Growth Factor 7; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Clinical trial; Child; Pathology; Oral;
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: Myeloablative and hematopoietic stem cells transplantation therapy (HSCT) often acts as side-effect to oral mucositis (OM) with no effective treatment. This randomized-controlled trial analyzed the efficacy of palifermin, administered as a dose during HSCT therapy, as primary prophylaxis on pediatric patients with acute lymphoblastic leukemia (ALL). METHODS: In this study forty-six patients (9-15 years) with B-cell acute lymphoblastic leukemia (B-ALL) were analyzed. The patients underwent allogenic HSCT conditioned by myeloablative regimen. Subsequently to randomization, patients in the palifermin group were assigned to receive palifermin, 60 mg/kg, intravenously as a single dose 3 days before and after transplant conditioning regimen cycle. The patients in the Control group received only a placebo treatment. Maximum severity of OM, incidence and duration of ulcerative OM, incidence and duration of severe OM limitations were evaluated. RESULTS: A statistically significant reduction in the incidence of OM up to grade 3 in the palifermin group compared to the control group was discovered. There was also a reduction, confirmed at 60 days, in the degree of severity of mucositis in the palifermin group, with an average of 1.54 grade in the palifermin group, and of 2.16 in the Control group and in the use of opioid analgesics. CONCLUSIONS: This study indicates that a single dose of palifermin used as primary prophylaxis during HSTC therapy can prevent severe OM in pediatric patients with ALL and used as secondary prophylaxis can prevent the recurrence of severe OM in high-risk patients with previous mucosal injury and improves the quality of life in pediatric patients with ALL.
引用
收藏
页码:43 / 53
页数:11
相关论文
共 50 条
  • [21] Effect of synbiotic mouthwash on oral mucositis induced by radiotherapy in oral cancer patients: a double-blind randomized clinical trial
    Soheila Manifar
    Maryam Koopaie
    Zahra Mofazal Jahromi
    Sajad Kolahdooz
    Supportive Care in Cancer, 2023, 31
  • [22] Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
    Elisa Kauark-Fontes
    Cesar Augusto Migliorati
    Joel B. Epstein
    Nathaniel Simon Treister
    Carolina Guimarães Bonfim Alves
    Karina Morais Faria
    Natalia Rangel Palmier
    Leticia Rodrigues-Oliveira
    Mariana de Pauli Paglioni
    Luiz Alcino Monteiro Gueiros
    Karina G. M. da Conceição Vasconcelos
    Gilberto de Castro
    Adriana Franco Paes Leme
    Marcio Ajudarte Lopes
    Ana Carolina Prado-Ribeiro
    Thaís Bianca Brandão
    Alan Roger Santos-Silva
    Supportive Care in Cancer, 2022, 30 : 2225 - 2236
  • [23] Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
    Kauark-Fontes, Elisa
    Migliorati, Cesar Augusto
    Epstein, Joel B.
    Treister, Nathaniel Simon
    Bonfim Alves, Carolina Guimaraes
    Faria, Karina Morais
    Palmier, Natalia Rangel
    Rodrigues-Oliveira, Leticia
    Paglioni, Mariana de Pauli
    Monteiro Gueiros, Luiz Alcino
    da Conceicao Vasconcelos, Karina G. M.
    de Castro Jr, Gilberto
    Paes Leme, Adriana Franco
    Lopes, Marcio Ajudarte
    Prado-Ribeiro, Ana Carolina
    Brandao, Thais Bianca
    Santos-Silva, Alan Roger
    SUPPORTIVE CARE IN CANCER, 2022, 30 (03) : 2225 - 2236
  • [24] Efficacy of gabapentin mouthwash in managing oral mucositis pain in patients undergoing chemotherapy: a prospective, randomised, double-blind, controlled clinical trial
    Ala, Shahram
    Zamani, Neda
    Akbari, Jafar
    Salehifar, Ebrahim
    Janbabai, Ghasem
    Koulaeinejad, Neda
    SCOTTISH MEDICAL JOURNAL, 2020, 65 (01) : 12 - 18
  • [25] N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial
    Moslehi, A.
    Taghizadeh-Ghehi, M.
    Gholami, K.
    Hadjibabaie, M.
    Jahangard-Rafsanjani, Z.
    Sarayani, A.
    Javadi, M.
    Esfandbod, M.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 (06) : 818 - 823
  • [26] N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial
    A Moslehi
    M Taghizadeh-Ghehi
    K Gholami
    M Hadjibabaie
    Z Jahangard-Rafsanjani
    A Sarayani
    M Javadi
    M Esfandbod
    A Ghavamzadeh
    Bone Marrow Transplantation, 2014, 49 : 818 - 823
  • [27] A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation
    Mark M. Schubert
    Fernanda P. Eduardo
    Katherine A. Guthrie
    Jean-Claude Franquin
    Rene-Jean J. Bensadoun
    Cesar A. Migliorati
    C. Michele E. Lloid
    Carlos P. Eduardo
    Niccoli-Filho Walter
    Marcia M. Marques
    Mohd Hamdi
    Supportive Care in Cancer, 2007, 15 : 1145 - 1154
  • [28] A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation
    Schubert, Mark M.
    Eduardo, Fernanda P.
    Guthrie, Katherine A.
    Franquin, Jean-Claude
    Bensadoun, Rene-Jean J.
    Migliorati, Cesar A.
    Lloid, C. Michele E.
    Eduardo, Carlos P.
    Walter, Niccoli-Filho
    Marques, Marcia M.
    Hamdi, Mohd
    SUPPORTIVE CARE IN CANCER, 2007, 15 (10) : 1145 - 1154
  • [29] Efficacy of quetiapine for delirium prevention in hospitalized older medical patients: a randomized double-blind controlled trial
    Saran Thanapluetiwong
    Sirasa Ruangritchankul
    Orapitchaya Sriwannopas
    Sirintorn Chansirikarnjana
    Pichai Ittasakul
    Tipanetr Ngamkala
    Lalita Sukumalin
    Piangporn Charernwat
    Krittika Saranburut
    Taweevat Assavapokee
    BMC Geriatrics, 21
  • [30] Efficacy of quetiapine for delirium prevention in hospitalized older medical patients: a randomized double-blind controlled trial
    Thanapluetiwong, Saran
    Ruangritchankul, Sirasa
    Sriwannopas, Orapitchaya
    Chansirikarnjana, Sirintorn
    Ittasakul, Pichai
    Ngamkala, Tipanetr
    Sukumalin, Lalita
    Charernwat, Piangporn
    Saranburut, Krittika
    Assavapokee, Taweevat
    BMC GERIATRICS, 2021, 21 (01)